Iowa Pharmacy CE Requirement 28-Hour Package
140
Included Courses
Courses included in this package. Click on a course to learn more.
- Diabetic Medications and Insulin Pump Therapies 6Release Date: 1/26/2021
About the Course:
Diabetes and glycemic medications are in the news every day. Staying ahead of current research and treatment options is an uphill challenge. This course provides the latest in diabetic medications and treatment options, including insulin pump therapies. - Managing the Unique Needs of Female Patients 3Release Date: 1/26/2021
About the Course:
This course covers women’s health management and medications used in this patient population. It reviews the physiology of female hormones and details the various hormonal and nonhormonal contraceptive methods available. Management of pregnant and lactating patients and medication use in these populations is included. The course also discusses menopausal treatment and the current recommendations regarding hormonal use in this population. Additionally, the epidemiology, pathophysiology, risk factors, and diagnosis of osteoporosis will be discussed. This course gives detailed information on the medications used to treat these conditions. - Medicinal Marijuana 5Release Date: 1/26/2021
About the Course:
This Medicinal Marijuana (Cannabis sativa) course includes coverage of recreational versus medicinal use, botanical background, cultural history, endocannabinoid system, FDA-approved cannabinoids, therapeutic uses, clinical research, federal and state marijuana laws, cannabis use disorder, nursing care/considerations for patients using medicinal marijuana. - Patient Safety and Medication Errors 3Release Date: 1/26/2021
About the Course:
The purpose of this course is to raise pharmacist awareness about the breadth, depth and potential consequences related to medication errors, and to review useful strategies to help avoid causing such errors. - Pharmacy Law Fundamentals 2Release Date: 1/26/2021
About the Course:
Pharmacy is the most regulated profession in healthcare. Beginning with the Food, Drug, and Cosmetics Act of 1938, legislation has been enacted to distinguish between prescription and OTC medications and to establish that drugs must be both safe and effective, must be properly labeled, and must be manufactured and stored under sanitary conditions. The Controlled Substances Act of 1970 provides a regulatory foundation for the distribution of controlled substances. This course reviews the history and fundamentals of pharmacy law, focusing on the FDCA and Amendments and the CSA, along with implications of these laws for practice and patient care today. - The Complications of Chronic Kidney Disease, Second Edition 2
Release Date: 7/10/2023
About the Course:
This course serves as a review of chronic kidney disease (CKD) and the medications used to prevent adverse effects of CKD and slow disease progression. - The Pharmacologic Management of Anxiety in Adults 2Release Date: 7/10/2023About the CourseAnxiety disorders are the most commonly diagnosed psychiatric disorders, with an estimated 264 million persons globally suffering from an anxiety disorder. It’s estimated that 19.1% of adults in the United States (U.S.) are affected by at least one anxiety disorder; this number increases to 31.9% in U.S. adolescents. Common anxiety disorders include generalized anxiety disorder (GAD), panic disorder (PD), specific phobias, agoraphobia, social anxiety disorder (SAD), and separation anxiety disorder. This course reviews the diagnosis and pharmacological management of anxiety disorders, as well as medications which can cause or exacerbate anxiety symptoms.
- The Role of the Pharmacist in the Opioid Crisis 5Release Date: 1/26/2021
About the Course:
Pharmacists in multiple practice settings are confronted daily with the need to strike an ethically acceptable balance between appropriate treatment of a patient’s chronic pain and the avoidance of opioid addiction. This course will provide pharmacists with an understanding of the disease state of opioid use disorder, how opioids affect the brain, and the benefits of medically-assisted treatment and harm-reduction approaches in certain populations of patients. Pharmacists will gain an understanding of appropriate pain management and current guidelines for the prescribing of opioids and will review ways that the safety of a patient’s opioid therapy can be evaluated and improved.